Doc Admits Letting Aegerion See Patient Data, Target Teens
By Alison Noon (February 28, 2018, 6:00 PM EST) -- A pediatric cardiologist helped Aegerion Pharmaceuticals Inc. target dozens of his teenage patients with heart conditions for an expensive medication approved only to treat an ultra-rare disease that none of them had, the doctor admitted in Massachusetts federal court on Wednesday.
Eduardo Montana pled guilty to sharing electronic medical records in 2013 without patient knowledge or consent. The head of two children's cardiovascular offices in Georgia at the time, Montana said he gave Aegerion representatives patient names, dates of birth, diagnoses and other private information to find potential buyers for Juxtapid, a cholesterol drug that cost at least $250,000 annually....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!